Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Oncoimmunology|November 21, 2015
Functional expression of CD137 (4-1BB) on T helper follicular cellsCarlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, et al.Journal for Immunotherapy of Cancer|October 1, 2018
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasisJavier Rodriguez, Eduardo Castañón, Jose Luis Perez-Gracia, et al.Journal for Immunotherapy of Cancer|November 26, 2021
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacyMaite Alvarez, Carmen Molina, Carlos E De Andrea, et al.Cancer Research|June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient MiceMiguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.Oncotarget|May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor modelsLeah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.Journal for Immunotherapy of Cancer|August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastomaOlaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.Journal for Immunotherapy of Cancer|February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor modelsEneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.Molecular Cancer|March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancerAntonin Levy, Daphné Morel, Matthieu Texier, et al.Signal Transduction and Targeted Therapy|March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial resultsAntonin Levy, Daphné Morel, Matthieu Texier, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.Pageof 7